The condition

What The Tinnitus Guideline Actually Says About Supplements

There is a published clinical practice guideline for ringing in the ears, it is freely readable, and it contains a specific recommendation about dietary supplements. Almost nobody selling one quotes it. Here is what it says, in its own words, and what a recommendation in the negative is worth.

By Quiet Tone Team · Last updated October 29, 2026 · 9 min read · The condition · Reviewed by Dr. Kelsee Lothes, Au.D

Tinnitus is a symptom, not a diagnosis

Ringing, buzzing, hissing or humming with no external source is a symptom. It is not a disease with a single cause, and that one sentence explains most of what follows.

It accompanies age-related hearing loss and noise damage, which are the two commonest associations by a wide margin. It also accompanies earwax pressing on an eardrum, some prescription medicines, problems with the jaw joint, and occasionally a vascular or structural cause that needs attention rather than patience.

Why that matters before anything is bought

A symptom with several possible causes cannot be treated without knowing which one is present. An audiogram is the test that starts that process, and the plain-English description of the pathway is freely available and takes ten minutes to read.

Somebody whose ringing comes from an impacted plug of wax has a five-minute solution. Somebody whose ringing comes from an untreated hearing loss has a well-evidenced route involving amplification. Neither is reachable from a capsule, and neither is identifiable without the assessment.

What a clinical practice guideline is

A clinical practice guideline is not one specialist's opinion. It is a document produced by a panel that reviews the published evidence systematically, grades it, and issues recommendations with the grading attached, so that a reader can see how confident the panel was and why.

The tinnitus guideline in question was produced by the American Academy of Otolaryngology, published in 2014, and runs to forty pages with a shorter executive summary alongside it. The full document is the reference every subsequent discussion of this condition in the United States starts from.

What the grading language does

A guideline distinguishes between a recommendation, an option and a recommendation against, and the distinction carries real information. An option means the panel found the evidence balanced enough that a clinician and a patient should decide together. A recommendation against means the panel looked and concluded that the intervention should not be offered.

That last category is uncommon. Panels are generally reluctant to close a door, because closing one requires evidence of absence rather than absence of evidence. When a panel does it anyway, the recommendation is worth reading carefully.

The recommendations, side by side

Here are the parts of the guideline that matter to somebody standing in front of a shelf of supplements, condensed into one table.

Summarised from the published guideline and its executive summary, both cited below. The wording in the middle column is the guideline's own grading language.

Read that table as a whole and a shape appears. Everything the guideline supports is about identifying the cause, correcting a hearing loss where one is present, or reducing the distress the sound causes. Nothing it supports is aimed at silencing the sound directly, because nothing reliably does.

The last row is the one this article is about, and it is worth restating precisely: ginkgo, melatonin, zinc or other dietary supplements, recommended against, for persistent bothersome tinnitus.

What a recommendation against actually means

There is a common misreading of that line worth heading off. It does not mean supplements are dangerous. It does not mean nobody has ever felt better while taking one. And it does not mean the panel refused to look.

It means the panel looked at the trial evidence for the supplements most often sold for this symptom, found that the better trials did not show benefit, weighed that against the cost and the opportunity cost of somebody treating themselves instead of being assessed, and concluded that the balance sits on the negative side.

Opportunity cost is the underrated half

The part of that reasoning most often left out is the second cost. A person who spends a year working through supplements is a person who has not had an audiogram for a year. If the ringing is accompanying a hearing loss that amplification would help, that year is the real expense rather than the money.

This is also why the guideline is emphatic about prompt assessment for ringing that is one-sided, pulsing, or accompanied by a sudden hearing change. Those presentations carry a different set of possible causes and the delay matters more.

The supplement trials the recommendation rests on

Recommendations rest on evidence, so here is the evidence, ingredient by ingredient.

The fourth row is the one that applies to nearly every bottle on sale in this category, including the one this website sells.

The Cochrane review of zinc is the most directly relevant row, because zinc is the ingredient that appears on nearly every label in this aisle. Three randomised trials, 209 adults between them, and no evidence that oral zinc improves tinnitus symptoms. The Cochrane review of ginkgo reaches a similar conclusion for the other most-sold ingredient in the category.

The fourth row is the one that catches people out. A multi-ingredient formula has not been tested; only some of its parts have, separately, at doses those parts were given alone. A formula does not inherit a finding from a trial of one ingredient, and it certainly does not inherit one from a trial that found nothing.

What a 2026 umbrella review adds

Guidelines date. This one is from 2014, so the fair question is whether anything has changed since.

A 2026 umbrella review gathered every tinnitus intervention with a meta-analysis behind it and mapped where the evidence actually sits. The answer is broadly the same as the guideline's: sound-based management, cognitive approaches and correcting a hearing loss carry the evidence, and dietary supplements do not appear among the interventions with support.

What would change the picture

A properly powered randomised trial of a finished multi-ingredient formula, against placebo, with a validated tinnitus outcome measure and a pre-registered protocol. Nothing of that description exists for any product in this aisle.

It would not be cheap, and it is worth being honest about why nobody runs one. A supplement seller who ran that trial and got a null result would have destroyed its own market; one who got a positive result would have a drug rather than a supplement, with a different regulatory route and a different cost base. The incentives point away from finding out.

So why does the aisle exist?

This is where a fair article has to stop quoting and start thinking. If the guideline says what it says, why is there a shelf of these products at all, and why do people keep buying them?

Three reasons, and none of them is stupidity.

1. The condition is common and distressing, and the interventions that work are not universally available. Cognitive behavioural therapy for tinnitus requires a therapist with the relevant training, and waiting lists are real.
2. Most of what is actually in these bottles is aimed at sleep and stress. Open a hearing formula and the ingredient list is dominated by calm-and-sleep botanicals. Sleeping badly makes a ringing more intrusive, and that relationship is not in dispute.
3. Doing nothing is intolerable. A person told there is no treatment will look for one anyway, and a bottle is the most available thing to try. That is a human response rather than a failure of reasoning.

The honest position, then, is not that this aisle is a fraud. It is that a buyer should know what they are buying: a set of ingredients whose evidence sits in sleep, stress and mood, sold beside a symptom that those states genuinely make worse, with no evidence that any of it touches the sound itself.

What to do with this if you already take something

Nothing on this page is a reason to throw a bottle away in a hurry. It is a reason to reorder the steps.

• Book the assessment if it has not happened. It is the one action that changes what is known, and everything else is easier to judge afterwards.
• Check the ingredient list against your prescriptions. Two ingredients common in this aisle interact with named drug classes and are the real safety question here.
• Set a date to decide rather than drifting. Most botanical trials read their endpoints at eight to twelve weeks, so that is a defensible point to stop and think.
• Keep a short record, including what else changed. Sleep, noise exposure and caffeine move the same experiences, and a record that misses them cannot separate anything.
• Know the refund terms before the second bottle rather than after the sixth.

Four questions worth asking about any tinnitus product

• Does the label make a claim about ringing or hearing? If it does, ask what evidence supports it, because the guideline above found none for this category.
• Which ingredients have been tested for this use, and what did those trials find? For zinc and ginkgo the answer is published and it is not encouraging.
• Is the finished formula tested, or only some of its parts? In this aisle the answer is always the latter.
• What is the ingredient list actually aimed at? On most of these labels the honest answer is sleep and stress, and a seller who says so plainly is being more useful than one who does not.

A product that answers those four honestly is not necessarily one worth buying. It is one worth taking seriously, which in this category is already a short list.

References